Beaird Harris Wealth Management, LLC Q3 2022 Filing

Filed November 2, 2022

Portfolio Value

$456.3B

Holdings

521

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (521 positions)

#StockSharesValue% PortfolioType
501
CABACABALETTA BIO INC
79$00.00%
502
FIXXEURHOMOLOGY MEDICINES INC
163$00.00%
503
BCELATRECA INC
77$00.00%
504
TDYTELEDYNE TECHNOLOGIES INC
1$00.00%
505
SRNESORRENTO THERAPEUTICS INC
196$00.00%
506
INSWINTERNATIONAL SEAWAYS INC
3$00.00%
507
TCR2 THERAPEUTICS INC
61$00.00%
508
CARLOTZ INC
200$00.00%
509
NVVENUVVE HOLDING CORP
250$00.00%
510
ORTXUSDORCHARD THERAPEUTICS PLC
120$00.00%
511
SHELSHELL PLC
9$00.00%
512
RBOTWVICARIOUS SURGICAL INC
250$00.00%
513
FATHOM DIGITAL MFG CORP
1,000$00.00%
514
ALCALCON AG
7$00.00%
515
GBYSANGAMO THERAPEUTICS INC
87$00.00%
516
HOOKGBPHOOKIPA PHARMA INC
92$00.00%
517
EBSEMERGENT BIOSOLUTIONS INC
12$00.00%
518
EP3ORASURE TECHNOLOGIES INC
83$00.00%
519
DJTDIGITAL WORLD ACQUISITION CO
22$00.00%
520
10X CAP VENTURE ACQSTN CORP
1,084$00.00%
521
CRMSALESFORCE INC
1$00.00%
PreviousPage 6 of 6